Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,570 | 33,617 | 40,667 | 45,877 | 49,391 |
| Marketable Securities | 48,105 | 44,171 | 34,918 | 45,260 | 40,549 |
| Receivables | 110,911 | 96,024 | 97,167 | 91,973 | 88,306 |
| Income taxes - deferred | 9,047 | 8,729 | 9,454 | 8,951 | 8,048 |
| Other current assets | 26,248 | 28,952 | 28,947 | 22,778 | 19,094 |
| TOTAL | $235,881 | $211,493 | $211,153 | $214,839 | $205,388 |
| Non-Current Assets | |||||
| PPE Net | 55,688 | 54,311 | 48,996 | 43,832 | 40,705 |
| Investments And Advances | 65,818 | 81,965 | 82,109 | 98,005 | 77,412 |
| Intangibles | 157,807 | 159,052 | 142,011 | 101,851 | 95,577 |
| Other Non-Current Assets | 43,100 | 46,658 | 47,605 | 47,303 | 40,954 |
| TOTAL | $322,413 | $341,986 | $320,721 | $290,991 | $254,648 |
| Total Assets | $558,294 | $553,479 | $531,874 | $505,830 | $460,036 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,260 | 10,342 | 10,258 | 9,988 | 8,374 |
| Accrued Expenses | 63,043 | 50,649 | 56,593 | 57,338 | 49,199 |
| TOTAL | $213,694 | $201,467 | $203,512 | $204,695 | $183,325 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 140,391 | 140,476 | 136,661 | 137,369 | 125,752 |
| Other Non-Current Liabilities | 5,616 | 5,943 | 2,852 | 2,824 | 2,783 |
| TOTAL | $29,035 | $32,254 | $28,911 | $22,075 | $19,344 |
| Total Liabilities | $242,729 | $233,721 | $232,423 | $226,770 | $202,669 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,712 | 32,069 | 31,808 | 31,745 | 31,143 |
| Common Shares | 318 | 321 | 317 | 312 | 312 |
| Retained earnings | 258,601 | 245,972 | 234,749 | 224,091 | 206,028 |
| Other shareholders' equity | -594 | -64 | 893 | 544 | 167 |
| TOTAL | $315,565 | $319,758 | $299,451 | $279,060 | $257,367 |
| Total Liabilities And Equity | $558,294 | $553,479 | $531,874 | $505,830 | $460,036 |